# IUS Combined With VAT Predicts Anti-TNF-α Efficacy in Patients With IBD: a Prospective Study

> **NCT06165029** · — · RECRUITING · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 50 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Intestinal Ultrasound
- Visceral Adipose Tissue
- TNF-α
- Predictors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06165029
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-22
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06165029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06165029, "IUS Combined With VAT Predicts Anti-TNF-α Efficacy in Patients With IBD: a Prospective Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06165029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*